Pharmacological Treatments for Patients with Treatment-Resistant Depression
Over a third of patients with major depressive disorder (MDD) do not have an adequate response to first-line antidepressant treatments, i.e., they have treatment-resistant depression (TRD). These patients tend to have a more severe course of illness and are at an increased risk of suicide. Next step...
Saved in:
Main Authors: | Valerie L. Ruberto (Author), Manish K. Jha (Author), James W. Murrough (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of depressive episode pharmacological treatment
by: Jakovljević Mihajlo B., et al.
Published: (2015) -
Excess deaths in treatment-resistant depression
by: Philip Brenner, et al.
Published: (2021) -
Treatment resistant depression in women with peripartum depression
by: M. Soledad Cepeda, et al.
Published: (2019) -
Treatment-resistant depression reconsidered
by: Hans S. Schroder, et al.
Published: (2022) -
Acupressure as an Adjunct to Pharmacological Treatment for Depression, Anxiety, and Stress in Patients with Knee Osteoarthritis
by: Meenu Rani, et al.
Published: (2020)